Gate Neurosciences
- Biotech or pharma, therapeutic R&D
Gate Neuro is a clinical-stage biotech currently syndicating a Series B financing. We are applying precision biomarkers to develop next-gen NMDAR PAMs for psychiatric & cognitive disorders. Our lead program, zelquistinel, is currently in Phase 2 for MDD.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}